Investor profile
Thuja Capital has backed 11 European tech companies across 13 funding rounds between 2014 and 2026, joining rounds totalling €163M. Most active in Healthtech and Hardware. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Salvia BioElectronics | Netherlands | 1 | €53M |
| AstriVax | Belgium | 1 | €30M |
| Gradient Denervation Technologies | France | 1 | €14M |
| NightBalance | Netherlands | 1 | €13M |
| Synerkine Pharma |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| AstriVax | Seed | €30M | 2022-08 |
| Gradient Denervation Technologies | Series A | €14M | 2023-09 |
| NightBalance |
| Netherlands |
| 3 |
| €12M |
| tacalyx | Germany | 1 | €11M |
| FundaMental Pharma | Germany | 1 | €10M |
| InnoSIGN | Netherlands | 1 | €7.3M |
| Cristal Therapeutics | Netherlands | 1 | €6.0M |
| EnCare Biotech | Netherlands | 1 | €4.4M |
| ATRO Medical | Netherlands | 1 | €3.0M |
| Series B |
| €13M |
| 2016-07 |
| tacalyx | Seed | €11M | 2026-04 |
| FundaMental Pharma | Seed | €10M | 2022-11 |
| InnoSIGN | Series A | €7.3M | 2022-04 |
| Cristal Therapeutics | Early VC | €6.0M | 2014-12 |
| Synerkine Pharma | Series A | €5.3M | 2023-10 |
| EnCare Biotech | Series A | €4.4M | 2014-11 |
